The news: New details on the Trump administration and European Union trade agreement solidify a 15% tariff cap on generics and active pharmaceutical ingredients, but leave questions on brand-name drug imports. The takeaway: Pharma companies can breathe a sigh of relief with the certainty of 15% EU tariffs and another reprieve, at least for now, on MFN pricing. Although the threat remains, the MFN deadline has already shifted once from June to September and could be moved again. That said, drugmakers should continue discussions while preparing for counter measures if needed such as US-only drug launches or raising prices abroad.

Estée Lauder posted a wider quarterly loss as sales slumped and warned that tariffs could reduce earnings by about $100 million over the next year. Estée Lauder is taking necessary steps to turn around its business—focusing on product innovation, cutting costs, and broadening its customer reach—but it will be tough given intense competition in the beauty market. With key rival L’Oreal gaining US momentum and newer brands emerging, Estée Lauder must accelerate product innovation, reduce reliance on discounting, rebuild momentum in China, and take other steps to win new customers, or risk ceding more ground in the longer term.

On today’s podcast episode, we discuss how the world’s largest online retailer is weathering tariffs so far, the biggest takeaway from Prime Day, and why Amazon’s AI future could be wearables. Join our conversation with Senior Director of Podcasts and host, Marcus Johnson, Senior Director of Briefings Jeremy Goldman, and Analyst, Rachel Wolff. Listen everywhere you find podcasts and watch on YouTube and Spotify.

Nearly two-thirds of US consumers (63%) believe businesses are taking advantage of the challenging economic climate to raise prices, according to a survey by The Harris Poll. Still, consumers shouldn’t be surprised by tariff surcharges at checkout. Businesses should avoid the urge to use tariffs as an excuse to pad their margins and instead aim to keep prices on popular items as steady as possible while clearly explaining unavoidable increases.

The news: Revolving consumer credit growth has been negative for two months, per Federal Reserve Board data. Annualized revolving credit growth declined 3.5% in May and 1% in June. A year ago, annualized revolving credit growth stood at 6.15% in May and -0.92% in June. Our take: In the face of uncertainty, consumers are wary of spending unless they feel incentivized to change their behavior, especially as tariff-related pressures increase.

The news: BlinkRx debuted a new quick startup direct-to-consumer (D2C) offering for pharma companies, on the heels of President Trump’s demand for more D2C drug distribution. Trump’s son, Donald Trump Jr, joined the board of BlinkRx in February. BlinkRx told Bloomberg it did not consult with Trump Jr. nor anyone in the Trump administration about the new offering. The takeaway: Pharma companies were already looking at new access models and ways to build direct connections to patients, but with the now pressing Trump demands, there’s new opportunity for digital health companies to offer vetted plug-and-play models.

A key inflation gauge that excludes food and energy prices picked up in July, suggesting tariff-related cost increases are being passed along to consumers. Core CPI, which strips out energy and food, rose 3.1% YoY, up from 2.9% in June. On a monthly basis, that closely watched measure rose 0.3%, the highest increase since January and up from June’s 0.2% advance. Retailers and producers are exhausting their early strategies to shield consumers and will need to plan for sustained cost pressures. Some strategies retailers can take on include negotiating with suppliers on cost-cutting measures or the use of lower-cost materials, exploring investments in onshoring production to avoid tariffs, and increasing D2C sales in a bid to improve profit margins.

Swiss footwear company On posted raised its full-year sales and gross margin outlook, citing broad-based geographical strength as Gen Z consumers scoop up its premium-priced athletic shoes.

The Trade Desk (TTD) posted Q2 revenues of $694 million, up 19% YoY and above expectations, driven by strength in connected TV and premium open-web inventory. However, cautious Q3 guidance cited slower advanced adtech adoption among large brands, macroeconomic budget pressures, and tariff-related spending risks. Shares fell nearly 40% in a day. For advertisers, the story underscores the open web’s importance as an alternative to walled gardens, with US programmatic open-web spend forecast to reach $48.8 billion by 2027. TTD’s future growth hinges on CTV, cross-channel targeting, and clean-room data collaboration to deliver premium inventory at scale.

The news: The FDA laid out a new FDA PreCheck initiative, aimed at helping pharma companies build US manufacturing plants more quickly. The takeaway: FDA PreCheck may ease manufacturing regulations and trim review time, but navigating real estate, construction, and skilled labor issues still means pharma companies are facing years-long timelines to reshore drug manufacturing. Trump has promised a year or two grace period on his proposed 250% tariffs, but that may not be long enough to get plants up and running. Pharma should look to cut deals—like Apple’s recent tariff exemption granted by Trump after it promised to invest $100 billion in US manufacturing—to guarantee exemptions as long as projects are underway.

The RealReal is upbeat about its prospects as tariffs and the uncertain environment boost resale’s appeal. While the company is not yet profitable, it is winning over more shoppers who see the circular economy as an opportunity to snag a good deal on luxury merchandise. Demand for resale is accelerating as consumers look for ways to escape tariffs and find better deals—not to mention shop more sustainably. While shoppers worried about saving money are unlikely to patronize a luxury-focused resale platform, The RealReal is in a good position to win spending from aspirational customers who are interested in luxury but are otherwise unwilling—or unable—to pay retail prices.

The news: President Donald Trump said he will enact 100% tariffs on all chips imported into the US, exempting companies that have promised to build or have begun building in the US. The plan was announced during a White House meeting with Apple CEO Tim Cook, who said Apple will invest another $100 billion in US manufacturing and jobs, bringing its total commitment to $600 billion, per The Financial Times. Our take: Brands should prepare for new marketing challenges and opportunities tied to supply chain visibility, patriotic manufacturing narratives, and potentially longer product cycles if companies reshore production. Keeping an eye on where key suppliers are building and how quickly they can pivot to US-based operations will be crucial in forecasting product costs and shaping future campaigns.

Ralph Lauren posted higher-than-expected quarterly results and raised its full-year revenue outlook, though it warned that tariffs could pressure consumer spending in the second half. Amid economic uncertainty, Ralph Lauren’s performance highlights the resilience of brands that sit at the intersection of aspiration and accessibility. The company appears better positioned than some of its luxury peers to weather volatility. Its quarterly results offer a blueprint for its retail peers, showing the value of a diversified supply chain and brand equity over aggressive discounting and heavy dependence on a single market.

High tariffs have become an unavoidable part of doing business in the US following the implementation of President Donald Trump’s sweeping reciprocal duties. Retailers are slowly becoming resigned to the fact that higher tariffs are here to stay—for now. But their ability to minimize business disruption is severely hampered by the fact that new tariffs can be imposed at any time, which could immediately turn any attempts to adjust sourcing into sunk costs. As e.l.f. Beauty CEO Tarang Amin told CNBC, “It’s the uncertainty around the tariffs that make things more difficult.”

The news: WPP has taken another hit in earnings, underscoring the current unstable market defined by economic uncertainty.Profits dropped 71% pre-tax in the first half of the company’s financial year, falling to £98 million ($125.2 million), while operating profit fell nearly half (47.8%), reaching £221 million ($282.3 million). Our take: WPP’s profit plunge serves as a wake-up call for agencies to accelerate transformation and prove value beyond media buying. In an AI-dominated landscape, advertisers are demanding more for less.

This is the first installment of our annual “Mexico Ad Spending Benchmarks” series, which helps ad buyers and sellers calibrate their spending and revenue mix against the market.

This is the first installment of our “Mexico Ad Spending Benchmarks” series, which helps ad buyers and sellers calibrate their spending and revenue mix against the market.

China is taking more decisive steps to encourage domestic consumption and rein in price wars that are fueling deflation and straining trade relations. Beijing said it would allocate an additional RMB 69 billion ($9.6 billion) to its consumer goods trade-in program starting in October, bringing the total funds issued this year to RMB 300 billion ($41.87 billion). At the same time, the government plans to “address disorderly competition among enterprises” and more closely scrutinize overcapacity in key industries, according to a Politburo statement. Addressing both issues—domestic consumption and damaging price wars—are key to China’s ability to weather higher tariffs and expand its influence on a global stage. But that’s easier said than done.

After advertisers spent Q1 2025 reacting to the threat of tariffs, they shifted their focus back to the business of figuring out how social platforms’ automated offerings complement more established methods of investment.